Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.81B |
| 2 |
Microsoft
MSFT
|
+$1.34B |
| 3 |
Apple
AAPL
|
+$1.25B |
| 4 |
Amazon
AMZN
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$480M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPLK
Splunk Inc
SPLK
|
+$373M |
| 2 |
Amgen
AMGN
|
+$204M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$180M |
| 4 |
IMGN
Immunogen Inc
IMGN
|
+$160M |
| 5 |
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.47% |
| 2 | Financials | 12.91% |
| 3 | Healthcare | 12.22% |
| 4 | Consumer Discretionary | 10.6% |
| 5 | Industrials | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
SunCoke Energy
SXC
$797M
| $20.8M | ﹤0.01% |
1,844,260
+51,031
| +3% | +$551K |
|
1902
A10 Networks
ATEN
$1.95B
| $20.8M | ﹤0.01% |
1,517,187
+32,789
| +2% | +$441K |
|
1903
Vita Coco
COCO
$3.6B
| $20.8M | ﹤0.01% |
849,928
+132,124
| +18% | +$3.07M |
|
1904
Crescent Energy
CRGY
$3.82B
| $20.7M | ﹤0.01% |
1,742,010
+32,303
| +2% | +$364K |
|
|
SLCA
1905
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $20.6M | ﹤0.01% |
1,659,565
+38,252
| +2% | +$428K |
|
|
BDN
1906
Brandywine Realty Trust
BDN
$554M
| $20.6M | ﹤0.01% |
4,287,440
+202,583
| +5% | +$939K |
|
|
BRSP
1907
BrightSpire Capital
BRSP
$648M
| $20.6M | ﹤0.01% |
2,984,555
+109,948
| +4% | +$768K |
|
1908
Zentalis Pharmaceuticals
ZNTL
$302M
| $20.5M | ﹤0.01% |
1,302,237
+48,500
| +4% | +$667K |
|
1909
First Advantage
FA
$4.12B
| $20.5M | ﹤0.01% |
1,264,840
+15,961
| +1% | +$260K |
|
1910
Healthcare Services Group
HCSG
$1.53B
| $20.4M | ﹤0.01% |
1,638,000
+42,015
| +3% | +$466K |
|
1911
Pan American Silver
PAAS
$21.6B
| $20.4M | ﹤0.01% |
1,364,893
+67,139
| +5% | +$926K |
|
1912
Viridian Therapeutics
VRDN
$2.67B
| $20.4M | ﹤0.01% |
1,164,272
+169,804
| +17% | +$3.29M |
|
|
HPP
1913
Hudson Pacific Properties
HPP
$779M
| $20.4M | ﹤0.01% |
451,276
+8,745
| +2% | +$461K |
|
1914
Barrett Business Services
BBSI
$804M
| $20.4M | ﹤0.01% |
642,756
+24,568
| +4% | +$713K |
|
1915
Chewy
CHWY
$9.63B
| $20.3M | ﹤0.01% |
1,276,992
+46,645
| +4% | +$838K |
|
1916
NCR Atleos
NATL
$3.44B
| $20.3M | ﹤0.01% |
1,028,033
+34,571
| +3% | +$740K |
|
|
GOGL
1917
DELISTED
Golden Ocean Group
GOGL
| $20.3M | ﹤0.01% |
1,566,237
+38,875
| +3% | +$447K |
|
|
LGF.B
1918
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $20.3M | ﹤0.01% |
2,176,529
+66,545
| +3% | +$616K |
|
|
ETNB
1919
DELISTED
89bio
ETNB
| $20.3M | ﹤0.01% |
1,740,867
+363,157
| +26% | +$4.02M |
|
1920
Protolabs
PRLB
$2.13B
| $20.3M | ﹤0.01% |
566,604
+7,039
| +1% | +$254K |
|
1921
Blue Bird Corp
BLBD
$2.18B
| $20.3M | ﹤0.01% |
528,311
+33,729
| +7% | +$1.03M |
|
1922
Innoviva
INVA
$1.48B
| $20.2M | ﹤0.01% |
1,325,433
+14,161
| +1% | +$222K |
|
1923
MiMedx Group
MDXG
$633M
| $20.2M | ﹤0.01% |
2,620,966
+82,784
| +3% | +$665K |
|
1924
Lemonade
LMND
$4.1B
| $20.2M | ﹤0.01% |
1,229,457
+27,934
| +2% | +$470K |
|
|
EFC
1925
Ellington Financial
EFC
$1.71B
| $20.2M | ﹤0.01% |
1,708,165
+67,912
| +4% | +$816K |
|
Similar funds
Geode Capital Management's Q1 2024 Portfolio in Review
As of Q1 2024, Geode Capital Management held 4,738 positions worth $1.08T, up 13% from $956B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Geode Capital Management deployed $32.6B of net new capital in Q1 2024, opening 85 new positions and adding to 3,720 existing holdings. Its largest new stake was Solventum: 2,733,775 shares worth $0.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Amgen, an estimated $204M trimmed.
- Geode Capital Management's largest Q1 2024 buy was Solventum: 2,733,775 shares worth $0.
- Geode Capital Management added most to NVIDIA in Q1 2024, an estimated $1.81B increase.
- Geode Capital Management's biggest Q1 2024 reduction was Amgen, cutting an estimated $204M.
- Geode Capital Management fully exited Splunk Inc in Q1 2024, selling an estimated $373M.
- Geode Capital Management's ten largest holdings make up 28% of its $1.08T portfolio in Q1 2024.
- Geode Capital Management opened 85 new positions and closed 123 in Q1 2024.
- Geode Capital Management's portfolio value rose 13% quarter-over-quarter to $1.08T.
Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.